Eiger BioPharmaceuticals, Inc.
Treatment of hepatitis delta virus infection with interferon lambda

Abstract:

Methods of treating a hepatitis delta virus (HDV) infection in a human patient are provided. In some embodiments, the method comprising administering to the patient a therapeutically effective amount of interferon lambda for at least four weeks.